The 13th five year plan of the hottest pharmaceuti

The "13th five year plan" of the pharmaceutical industry places pharmaceutical packaging as a key direction

release date: Source: Internet editor: lychee browsing times: 1178 copyright and disclaimer

core tip: the "13th five year plan" should focus on improving the pharmaceutical packaging industry, coordinating, promoting and leading the development of pharmaceutical preparations, ensuring the goal and path of drug quality and drug safety, and adapting to the diversified development needs of the pharmaceutical industry, With the deepening of the reform of the pharmaceutical industry, the requirements for drugs and packaging are becoming higher and higher. Drug packaging materials should meet the development and requirements of the pharmaceutical industry, and establish the development goal of the drug packaging materials industry with clinical drug safety as the core

[China Packaging News] the "13th five year plan" should focus on achieving the goal and path of improving the pharmaceutical packaging industry, coordinating, promoting and leading the development of pharmaceutical preparations, ensuring drug quality and drug safety, and adapting to the diversified development needs of the pharmaceutical industry. With the deepening of industrial reform, the requirements for drugs and packaging are getting higher and higher. Drug packaging materials should adapt to the development and requirements of the pharmaceutical industry, and establish the development goal of the drug packaging materials industry with clinical drug safety as the core

during the 12th Five Year Plan period, the growth of major economic indicators of China's pharmaceutical industry slowed down, but higher than the overall growth rate of the national industry. The compound growth rate of the main business income of the enterprise is 17.4%, and the compound growth rate of the total profit is 14.5%. The proportion of the added value of the pharmaceutical industry in the national industrial industry has gradually increased. The annual growth rate in 2015 was 9.8%, 3.7 percentage points higher than the overall growth rate of the national industry. The growth of pharmaceutical exports slowed down and the export structure improved. The export of chemical pharmaceutical preparations has increased by 17.3% on a compound annual basis since the 12th Five Year Plan; Its proportion in total pharmaceutical exports increased from 3.8% in 2010 to 5.35% in 2014. The export growth of preparations has led to the improvement of the quality of drug packaging products, and the export speed of drug packaging products has increased, which are controlled by equipment. According to data analysis, the export growth rate of various products of drug packaging materials during the "12th Five Year Plan" period was about 10% on average, especially the registration and production of a batch of new biological drugs, which widened the development space for a series of new drug packaging materials such as high-end drug packaging materials cop bottles and dry powder inhalation devices

it is estimated that by 2020, the scale efficiency of the pharmaceutical industry will grow steadily, and the main business income will maintain a medium to high growth rate, with an average annual growth rate of more than 10%, accounting for a significant increase in the proportion of the industrial economy. The innovation ability has been significantly enhanced, the product quality has been comprehensively improved, the supply guarantee system has been improved, the pace of internationalization has been significantly accelerated, and the overall quality of the pharmaceutical industry has been significantly improved. Pharmaceutical excipients and packaging materials are two key directions for the development goal of the pharmaceutical industry in the 13th five year plan. In the field of pharmaceutical packaging materials, it is necessary to speed up the product upgrading of packaging systems, develop drug delivery devices of packaging systems, develop and apply new materials with high safety and good quality performance, and phase out varieties with high quality and safety risks. Focus on accelerating the transformation of injection packaging from low borosilicate glass bottles to neutral borosilicate glass bottles, developing new materials such as cycloolefin polymers and styrene thermoplastic elastomers used in syringes, infusion bags, blood bags and other products, high barrier materials for easily damp and oxidizable drugs, and improving the quality level of pharmaceutical grade polypropylene, polyethylene and halogenated butyl rubber. Develop new packaging systems and drug delivery devices, provide specific functions, meet the technical requirements of preparations, improve patient compliance, and ensure drug safety. Focus on the development of aerosol dosing devices and special dosing devices for powder aerosols, new syringes such as self dosing syringes, pre filling syringes, automatic mixing devices, multi compartment bags, infusion packaging with the function of removing insoluble particles, and intelligent packaging systems with memory functions and quality monitoring functions, Another change commonly used in families is that some hygroscopic plastics are hygroscopic, and this polylactic acid appears in children's safety packaging and elderly friendly packaging